Rostami A, White K, Rostami K. Pro and anti-inflammatory diets as strong epigenetic factors in inflammatory bowel disease. World J Gastroenterol 2024; 30(27): 3284-3289 [PMID: 39086746 DOI: 10.3748/wjg.v30.i27.3284]
Corresponding Author of This Article
Kamran Rostami, FRACP, MD, PhD, Doctor, Research Scientist, Department of Gastroenterology, Palmerston North Hospital, 50 Ruahine Street, Roslyn, Palmerston North 4442, New Zealand. kamran.rostami@midcentraldhb.govt.nz
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Jul 21, 2024; 30(27): 3284-3289 Published online Jul 21, 2024. doi: 10.3748/wjg.v30.i27.3284
Pro and anti-inflammatory diets as strong epigenetic factors in inflammatory bowel disease
Adele Rostami, Kristen White, Kamran Rostami
Adele Rostami, Digestive Health Clinic, Palmerston North 4410, New Zealand
Kristen White, Digestive Health Clinic & Kōtare Wellness Ltd, Palmerston North 4410, New Zealand
Kamran Rostami, Department of Gastroenterology, Palmerston North Hospital, Palmerston North 4442, New Zealand
Author contributions: Rostami A, White K and Rostami K reviewed the literature and wrote the editorial.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Kamran Rostami, FRACP, MD, PhD, Doctor, Research Scientist, Department of Gastroenterology, Palmerston North Hospital, 50 Ruahine Street, Roslyn, Palmerston North 4442, New Zealand. kamran.rostami@midcentraldhb.govt.nz
Received: April 7, 2024 Revised: June 16, 2024 Accepted: June 28, 2024 Published online: July 21, 2024 Processing time: 95 Days and 2.4 Hours
Abstract
Inflammatory bowel disease (IBD) is the consequence of a complex interplay between environmental factors, like dietary habits, that alter intestinal microbiota in response to luminal antigens in genetically susceptible individuals. Epigenetics represents an auspicious area for the discovery of how environmental factors influence the pathogenesis of inflammation, prognosis, and response to therapy. Consequently, it relates to gene expression control in response to environmental influences. The increasing number of patients with IBD globally is indicative of the negative effects of a food supply rich in trans and saturated fats, refined sugars, starches and additives, as well as other environmental factors like sedentarism and excess bodyweight, influencing the promotion of gene expression and increasing DNA hypomethylation in IBD. As many genetic variants are now associated with Crohn's disease (CD), new therapeutic strategies targeting modifiable environmental triggers, such as the implementation of an anti-inflammatory diet that involves the removal of potential food antigens, are of growing interest in the current literature. Diet, as a strong epigenetic factor in the pathogenesis of inflammatory disorders like IBD, provides novel insights into the pathophysiology of intestinal and extraintestinal inflammatory disorders.
Core Tip: This editorial highlights the implication of environmental factors, in particular diet, as epigenetic factors in pathogenesis of inflammatory bowel disease (IBD). The concept of epigenetic factors involved in the genesis of IBD brings new insight into the identified risk factors and future targeted approaches, as a guide to the prevention and treatment of IBD.